Nicotine polacrilex 2 mg Chewing Gum
RxNorm 314119
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 314119 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: nicotine polacrilex 2 mg Chewing Gum.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Nicotine 2 mg Chewing Gum
(Atom ID: 12340189)
PTPrescribable
Designated preferred name (PT):
Nicotine (as nicotine polacrilex) 2 mg oral gum chewing gum
(Atom ID: 11437758)
SYPrescribable
Synonym (SY):
Nicotine 2 mg (as nicotine polacrilex 11.1 mg) Chewing Gum
(Atom ID: 5911577)
PSNPrescribable
Prescribable Name (PSN):
Nicotine polacrilex 2 mg Chewing Gum
(Atom ID: 6366115)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely nicotine (as nicotine polacrilex) 2 mg/1 chewing gum prolonged-release oral gum (clinical drug)
(Atom ID: 11440387)
Patient Education
Nicotine Gum
Nicotine chewing gum is used to help people stop smoking cigarettes. Nicotine chewing gum should be used together with a smoking cessation program, which may include support groups, counseling, or specific behavioral change techniques. Nicotine gum is in a class of medications called smoking cessation aids. It works by providing nicotine to your body to decrease the withdrawal symptoms experienced when smoking is stopped and as a substitute oral activity to reduce the urge to smoke.
[Learn More]
* Please review the disclaimer below.